Skip to main content

Table 4 Complications association with combination regimen among Cohort

From: Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia

Regimen design Complications N/Total. (%) χ2 value ǂ
Metformin (monotherapy) 94/105. (89.5) 0.001
Lovastatin (monotherapy) 364/416. (87.5) 0.001
Sulfonlyurea 336/384. (87.5) 0.023
Insulin 70/73. (95.9) 0.001
Insulin & Oral hyperglycemic agent 61/64. (95.3) 0.001
Metformin & Diuretics 95/95. (100.0) 0.000
Metformin & Calcium Channel block 17/17. (100.0) 0.000
Metformin & Digoxin 2/2. (100.0) 0.000
Metformin & corticosteroid 9/9. (100.0) 0.000
Metformin & Nefidine 87/87. (100.0) 0.000
Lovastatin & Gemfibrozil 17/17. (100.0) 0.000
Lovastatin & other combinations 61/68. (89.7) 0.018
  1. ǂ all the variables were in 2 × 2 type (as. Metformin = monoXcomb..etc), Similarly complications section is dictomise into (yes & no). Sig. value is taken on individual analysis latter compressed in this table